CARLOS MANUEL
PANIZO SANTOS
Memorial Sloan Kettering Cancer Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (2)
2023
-
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
Blood Advances, Vol. 7, Núm. 17, pp. 4926-4935
2022
-
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma
Leukemia and Lymphoma, Vol. 63, Núm. 4, pp. 821-833